|
NUP35 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.528500E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.004000E-01 |
| Normal-vs-Stage2 |
1.188450E-01 |
| Normal-vs-Stage3 |
7.934500E-02 |
| Normal-vs-Stage4 |
4.760500E-02 |
| Stage1-vs-Stage2 |
1.311390E-01 |
| Stage1-vs-Stage3 |
7.296200E-02 |
| Stage1-vs-Stage4 |
8.817600E-02 |
| Stage2-vs-Stage3 |
9.470400E-01 |
| Stage2-vs-Stage4 |
6.359000E-01 |
| Stage3-vs-Stage4 |
6.923600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.005800E-01 |
| Normal-vs-AfricanAmerican |
3.055600E-01 |
| Normal-vs-Asian |
1.375760E-01 |
| Caucasian-vs-AfricanAmerican |
7.683600E-01 |
| Caucasian-vs-Asian |
6.046100E-02 |
| AfricanAmerican-vs-Asian |
1.331810E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.938400E-01 |
| Normal-vs-Female |
6.019900E-03 |
| Male-vs-Female |
1.049860E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.165600E-01 |
| Normal-vs-Extreme_Weight |
8.346400E-01 |
| Normal-vs-Obese |
5.292400E-02 |
| Normal-vs-Extreme_Obese |
7.456800E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.249400E-01 |
| Normal_Weight-vs-Obese |
2.260000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.458200E-01 |
| Extreme_Weight-vs-Obese |
5.845900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.649600E-01 |
| Obese-vs-Extreme_Obese |
6.065800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.755800E-03 |
| Normal-vs-Age(41-60Yrs) |
7.124800E-03 |
| Normal-vs-Age(61-80Yrs) |
5.935000E-01 |
| Normal-vs-Age(81-100Yrs) |
9.913200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.089800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.781100E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.324300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.481200E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.313200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.411000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.804300E-02 |
| Normal-VS-Type2 PRCC |
5.254800E-01 |
| Normal-VS-KIRP CIMP |
1.912430E-02 |
| Normal-VS-Unclassified PRCC |
3.988400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.622300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.564400E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
9.854600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.566700E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
2.317000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.088500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.590600E-01 |
| Normal-vs-N1 |
2.143900E-03 |
| Normal-vs-N2 |
9.477000E-01 |
| N0-vs-N1 |
2.537600E-03 |
| N0-vs-N2 |
9.856800E-01 |
| N1-vs-N2 |
2.087200E-01 |
|
|
